Ocugen (OCGN) Soars Suddenly Last Week: Is The Best News To Come?

Over the past months, many companies have seen their stocks soar on the back of their work regarding the coronavirus vaccine. However, in recent months, a new company has joined the race in the form of Ocugen Inc (NASDAQ: OCGN).

Ocugen (OCGN) Soars Suddenly Last Week: Is The Best News To Come?

As a matter of fact, the Ocugen stock has outperformed many of the rivals, and this past Friday, it gained another 37% as investors continued to pile on to it. The company is currently in discussions with the United States Food and Drug Administration about an Emergency Use Authorization for its coronavirus vaccine.

In early February, Ocugen had also reached an agreement with Indian company Bharat Biotech to collaborate on the commercialization and development of Covaxxin, the COVID 19 vaccine. The company has seen its stock soar by as big as 350% this year so far and its market cap has also hit $1.56 billion. At the start of the year, Ocugen commanded a market cap of only $350 million.

Emile Ortega

Editor and Computer ExpertA hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.